Redsense signs distribution agreement for Belgium, first order expected soon
Redsense Medical has signed a distribution agreement for Belgium with Medicole BVBA, a company that also holds the distribution rights for directly compatible hemodialysis machines from Redsense’s collaboration partner Nikkiso. A first order worth approximately 0,1 MSEK is expected soon.
Medicole BVBA has over 15 years of experience as a Belgian distributor of medical equipment. The company will now be able to offer the Redsense system for monitoring, alarm and automatic stop of the blood flow if a blood leakage occurs during hemodialysis to its clients.
“Belgium is one of the smaller countries in Europe, but the market is interesting for us as its health care system is of high standard, and there is also a push towards home dialysis due to new legislation. This means that we have an excellent opportunity to establish Redsense as a standard for the best patient safety possible in this growing market segment,” says Patrik Byhmer, CEO of Redsense Medical.
Earlier this year, Redsense Medical signed a letter of intent with the Netherland-based company Dirinco regarding a distribution agreement for the entire Benelux region. The letter of intent includes Belgium as Dirinco is expected to become the distributor for Nikkiso dialysis machines in the country. As this change has not yet been finalized, all parties agree that a distribution agreement between Redsense Medical and the current Nikkiso distributor in Belgium is the best solution to not risk losing momentum in the country.
For more information, please contact
Patrik Byhmer, CEO Redsense Medical AB (publ)
Telephone: +46 (0) 35 - 10 60 30
About Redsense Medical
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense system, a medical technology product used for monitoring and alarm in the case of blood leakage in connection with hemodialysis. Redsense solves one of the most serious remaining safety problems within hemodialysis – to quickly detect venous needle dislodgement and catheter leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.
This information is such information that Redsense Medical AB (publ) is obligated to publish in compliance with the EU market abuse regulation. The information was provided, through the above contact, for publication on the 14th of December 2017.